["{\n\"step_by_step_thinking\": \"Based on the provided documents, we can identify that the patient is eliminating 0.5 mg of the drug every 4 hours. This suggests that the anticoagulant being consumed is a low molecular weight heparin (LMWH), as they have distinct prophylactic antithrombotic efficacy characteristics. Specifically, the option B: Enoxaparin is an LMWH, which matches the patient's elimination pattern.\",\n\"answer_choice\": \"B\"\n}"]